Product Information
LEVETIRACETAM 500 MG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.0736 per EA under NDC 00378561578. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Nov 4, 2008. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
500 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378561578
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LEVETIRACETAMApproval Type
Generic (ANDA)
FDA Application
ANDA076919FDA Approved
11/4/2008
TE Code
AB
On Market Since
11/4/2008
Pharmacological Classes
Price Statistics
The NADAC for LEVETIRACETAM 500 MG TABLET has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 46.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0736 per EA |
|---|---|
| All-time high | $0.1431 (Jan 15, 2014) |
| All-time low | $0.0608 (Nov 20, 2024) |
| 52-week high | $0.0780 |
| 52-week low | $0.0736 |
| Median price | $0.1010 |
| Average price | $0.1044 |
| Largest weekly change | -26.6% (Nov 20, 2024) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Mylan Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
levetiracetam market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LEVETIRACETAM 500 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LEVETIRACETAM 500 MG TABLET, manufactured by Mylan Pharmaceuticals Inc., is $0.0736 per EA (NDC 00378561578), effective Sep 30, 2026.
How has the price of LEVETIRACETAM 500 MG TABLET changed over time?
Over the history we have for it, the NADAC for LEVETIRACETAM 500 MG TABLET has declined 46.1%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for LEVETIRACETAM 500 MG TABLET?
Since Nov 28, 2013, the NADAC for LEVETIRACETAM 500 MG TABLET has ranged from a low of $0.0608 (Nov 20, 2024) to a high of $0.1431 (Jan 15, 2014), with a median of $0.1010 per EA.
Are there cheaper alternatives to LEVETIRACETAM 500 MG TABLET?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LEVETIRACETAM 500 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures LEVETIRACETAM 500 MG TABLET?
LEVETIRACETAM 500 MG TABLET (NDC 00378561578) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.